The global anti-migraine drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The market growth is mainly attributed to the rising cases of migraine across the globe coupled with growing clinical trials for anti-migraine drugs. According to the Migraine Research Foundation, migraine is the 3rd largest prevalent disease across the globe. In 2018, more than 1 billion people were suffering from migraine. As per the same source, migraine is most prevalent between the age of 18 and 44 and mostly occurred in women more than men. Further, in 2018, there were around 39 million cases of migraine in the US alone. This further provides a boost to the global anti-migraine drugs market.
To Request a Sample of our Report on Anti-Migraine Drugs Market: https://www.omrglobal.com/request-sample/anti-migraine-drugs-market
Some key players operating in the market include Eli Lilly & Co., Abbott Laboratories, and Allergan plc, among others. These players are eyeing on strengthening their position in the market by adopting various strategies such as mergers and acquisitions, partnerships and collaborations, new product launches and development in the existing product portfolio, and so on. Further, pipeline clinical trials by various pharmaceutical companies such as Amgen Inc., and Allergen plc, among others further provide ample opportunity to the market growth. For instance, in March 2019 Axsome Therapeutics, Inc. started the phase III clinical trial for drugs AXS-07, Meloxicam, Rizatriptan, and Placebo for the treatment of acute migraine. AXS-07 is an oral, investigational medicine consisting of MoSEIC meloxicam and rizatriptan, which is being developed for the acute treatment of migraine with or without aura in adults. Such activities are further projected to offer substantial growth opportunities to the global anti-migraine drugs market during the forecast period.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Eli Lilly & Co., Abbott Laboratories, and Allergan plc, among others.
(Get 15% Discount on Buying this Report)
A full Report of Anti-Migraine Drugs Market is Available @ https://www.omrglobal.com/industry-reports/anti-migraine-drugs-market
Global Anti-Migraine Drugs Market Report by Segment
By Type
- Triptans
- Ergots
- Others
By Application
- Men
- Women
Global Anti-Migraine Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
